Clinical Study

Intravenous Oxycodone versus Intravenous Morphine in Cancer Pain: A Randomized, Open-Label, Parallel-Group, Active-Control Study

Figure 1

Study design and visit schedule. At screening, patients can be randomized if average pain intensity NRS score during previous 7 days is ≥4. IV = intravenous, NRS = Numerical Rating Scale (0–10 points, 0 = no pain and 10 = worst pain), PGIC/CGIC = Patient Global Impression of Change/Clinical Global Impression of Change, R = randomization.